ABSTRACT. Telomeres are specific structures present at the end of liner chromosomes. DNA polymerase can not synthesize the end of liner DNA and, as a result, the telomeres become progressively shortened by successive cell divisions. To overcome the end replication problem, telomerase adds new telomeric sequences to the end of chromosomal DNA. The enzyme activity is undetectable in most normal human adult somatic cells, in which shortening of the telomere is thought to limit the somatic-cell life span. In contrast to normal somatic cells, many human tumors possess telomerase activity. The present study looked at whether telomerase activity might serve as a marker for canine tumors. Telomerase activity was measured using the telomeric repeat amplification protocol assay. Normal dog somatic tissues showed little or no telomerase activity, while normal testis exhibited a high level of telomerase activity. We measured telomerase activity in tumor samples from 45 dogs; 21 mammary gland tumors, 16 tumors developed in the skin and oral cavity, 7 vascular tumors and 1 Sertoli cell tumor. Greater than 95% of the tumor samples contained telomerase activity (3~924 U/2 µg protein). The results obtained in this study indicated that telomerase should be a useful diagnostic marker for a variety of dog tumors, and it may serve as a target for antitumor chemotherapy.-KEY WORDS: canine, telomerase, tumor, tumor marker.
telomerase activity. In contrast, many human tumors are known to have a high level of telomerase activity [14, 24] , and its activity can be thought of as a tumor marker. Furthermore, since the telomerase activity is specifically high in tumor cells relative to normal somatic cells, telomerase inhibitors have potential as new anti-cancer drugs [11, 22, 25] .
In comparison to humans, mice have much longer telomeres [15] , and they possess different telomerase activities in different normal somatic cell types [23, 28] . These variances in the mouse telomere and telomerase from those of human make the mouse an unlikely model for the human telomeric system.
In small animal veterinary practices, a variety of tumors are frequently observed in dogs. We measured telomerase activity in dog tumors hoping that it might serve as a useful marker for canine tumor diagnosis and as a putative target for novel chemotherapy.
MATERIALS AND METHODS
Tissue samples: Tumor samples were obtained from dogs with various tumors (Table 1) at surgical resection or at necropsy immediately after death at the Veterinary Medical Center, the University of Tokyo. All tissues were washed with physiological saline solution immediately after removal. These tissue samples were then rapidly frozen in liquid nitrogen and stored at 80°C for later use.
Telomerase activity assay: Telomerase activity was measured by using a polymerase chain reaction (PCR)-based telomerase activity assay, called telomeric repeat amplification protocol (TRAP) assay. This assay was Telomeres are specific structures present at the end of liner chromosomes. The telomeres consist of highly conserved tandemly repeated guanine-rich sequences such as TTAGGG in vertebrates. Telomeric length is approximately 10 to 20 kb per chromosome end in humans [17, 19] . Telomeric repeats associate with specific binding proteins [3, 7] . The presence of telomeres protect chromosomes from DNA degradation, end-to-end fusions, rearrangements and chromosome loss [3, 26] . During DNA replication, a newly synthesized strand that is formed continuously is called a leading strand, whereas a newly synthesized strand formed discontinuously (making Okazaki fragments) is called a lagging strand. DNA polymerases synthesize DNA in the 5´ to 3´ direction and require an RNA primer for initiation, which means that DNA polymerase can not synthesize a complete daughter strand at the very ends of lagging strands, and the telomeres become progressively shortened by cell division [27] . After a certain number of cell divisions, shortening of the telomeres results in cells that can no longer divide and fall senescent. Telomeric length, therefore, is referred to as a mitotic clock [3, 5, 9, 12, 29] .
Telomerase adds new telomeric sequences to the end of chromosomal DNA, thereby overcoming the end-replication problem. The telomerase consists of an essential RNA template and protein components including a kind of reverse transcriptase [10, 18, 21] . Telomerase binds to the 3´ end of the single-stranded region of chromosomal DNA. Then, the sequence repeats are added to the end of the DNA using the internal RNA as a template [10, 18, 21] . In humans, most of the somatic cells in adults have undetectable or low telomerase activity, although gonadal cells have distinct performed as described by Kim et al. [14] , using the TRAPeze telomerase detection kit (Oncor, Gaithersburg, MD). This kit was originally developed for measurement of telomerase activity in humans, but telomere sequence (telomerase adding sequence) was shown to be conserved in vertebrates [17] . Therefore, the TRAPeze telomerase detection kit was used for measurement of dog telomerase activity in this study. Briefly, frozen tissue samples were homogenized in a lysis buffer containing 0.5% 3-[(3-Cholamidopropyl) dimethylammonio)]-1-propanesulfonate. After incubation on ice for 30 min, the samples were centrifuged and the supernatant was rapidly frozen in liquid nitrogen and stored at 80°C. The protein content in the sample was measured using the Bradford assay [6] (Bio-Rad protein assay kit) (Bio-Rad Laboratories, Hercules, CA). A sample of extract containing 2 µg of protein was used for each TRAP assay. The 5´-end of TS primer (a substrate oligonucleotide of telomerase, 5'-AATCCGTCGAGCAGAGTT-3') was labeled with γ-32 P-ATP (Amersham, Buckinghamshire, England) and T4 polynucleotide kinase (Toyobo, Osaka, Japan). Two µl of the cell extract containing 2 µg of protein was incubated in 50 µl of reaction mixture supplied by the manufacturer containing dNTPs, TS primer, RP primer, K1 primer, TSK1 template and Taq polymerase (Takara, Kyoto, Japan) at 30°C for 30 min (first step); this mixture was then subjected to 27 cycles of PCR consisting of denaturation at 94°C for 30 sec and annealing and polymerization at 60°C for 30 sec (second step). In the first step, telomerase adds telomeric repeats to the 3' end of TS primer. In the second step, the extended products are amplified by PCR using the TS and RP primers, generating a ladder of oligonucleotide multiples. TSK1 template, K1 primer and TS primer produce an internal standard for telomerase amplification (ITAS). ITAS can be used to estimate the contamination of inhibitors for Taq polymerase and/or the efficiency of PCR amplification in each sample. As a negative control, each cell extract was heat-inactivated at 85°C for 10 min. Because telomerase is a heat sensitive enzyme, if there is no contamination, the PCR products generated through telomerase activity should be abolished. To quantitate telomerase activity, TRAP assay was performed using TSR8 control template, 5'-AATCCGTCGAGCGAGAGTTAG (GGTTAG) 7 -3' (TS primer + 8 telomeric repeats), instead of the cell extract. The PCR products were separated by electrophoresis in a 12.5% nondenaturing polyacrylamide gel. Then, the gel was dried on a filter paper and exposed to an X-ray film with an intensifying screen.
Telomerase activity was quantitated by comparing the densitometric intensities of the signals (Molecular Analyst, Bio-Rad Laboratories) using the following formula. TPG (Total Product Generated) (units) = ((X-X 0 )/C)/((r-r 0 )/C R ) × 100 X, X 0 , r, and r 0 are the signals corresponding to the ladder bands derived from non-heat-inactivated sample, heatinactivated sample, TSR8, and lysis buffer, respectively. C and C R are the signals from ITAS in non-heat-inactivated sample and TSR8, respectively.
RESULTS
A representative TRAP assay result is shown in Fig. 1 . Signals representing telomerase activity appeared as ladders of oligonucleotide multiples, which were abolished in heatinactivated samples.
Twenty-one tumor samples from dogs with mammary gland tumors including 9 benign mixed tumors, 5 mammary gland adenomas, 3 malignant mixed tumors and 4 mammary gland adenocarcinomas were examined for telomerase activity. The tumor samples from 20 of 21 dog mammary gland tumors contained telomerase activity from 3 to 390 U/2 µg protein of tumor tissues, whereas 4 canine normal mammary gland samples from dogs did not have detectable telomerase activity (Table 2 ). Only one sample from a malignant mixed tumor case (case 16) did not have detectable telomerase activity. There was no significant difference in telomerase activity among mammary gland tumors of different histologic types in dogs.
Sixteen skin tumors consisting of 3 perianal gland adenomas, 2 perianal gland adenocarcinomas, 6 sebaceous epitheliomas, 1 trichoepithelioma, 1 basal cell tumor, 1 epulis, 1 squamous cell carcinoma and 1 malignant melanoma were examined. As shown in Table 1 , all the The telomerase activity was examined before (-) and after (+) heat inactivation. TSR8 is a control template. ITAS indicates an internal standard for telomerase amplification.
skin tumors contained telomerase activity from 4 to 924 U/ 2 µg protein of tumor tissues, but normal skin samples from 5 dogs did not have any detectable telomerase activity (Table  2) . Relatively high telomerase activities with more than 100 U/2 µg protein were found in 11 of 16 skin tumors in dogs. Six samples from hemangiopericytoma in dogs had high levels of telomerase activity, and one sample of hemangiosarcoma (case 44) did not contain detectable telomerase activity (Table 1) . In addition to these tumors, distinct telomerase activity was found in 1 Sertoli cell tumor (290 U/2 µg protein) ( Table 1) . Four normal testis samples also contained a high degree of telomerase activity, which was similar to that shown in a Sertoli cell tumor sample.
DISCUSSION
In this study, telomerase activity was detected in almost all the tested tumor samples (43 out of 45 cases), whereas it was undetectable or low in normal somatic tissues in dogs. These results show that telomerase activity may be a diagnostic marker for tumors in dogs. Recently, Biller et al. [2] reported the detection of telomerase activity in high percentage of dog tumors as shown in this study. But they did not carry out precise quantitation of telomerase activity in each tumor sample. Quantitative measurement of telomerase activity in each tumor sample in this study will provide useful informations to establish a diagnostic system for dog tumors by estimation of telomerase activity.
In most normal somatic cells with undetectable or very low telomerase activity, the length of the telomeres becomes progressively shortened after serial cell division [5, 12] . This lack of telomerase is considered to be one of the reasons that most somatic cells have a limited number of cell divisions [5, 12] . On the other hand, tumor cells are considered to possess unlimited growth potential, which may be an effect of their highly active telomerase maintaining their telomeres [9, 13] . In this study, telomerase activity was detected in most of the dog tumors of various cell origins, therefore, telomerase may have an important role in tumorigenesis in dogs. Interestingly, there was no significant difference in telomerase activity among mammary gland tumors of different histologic classification in dogs. Furthermore, elevated telomerase activity was also detected in most of the benign tumors in dogs such as perianal gland adenomas and sebaceous epitheliomas. These data may suggest that, in dogs, reactivation of telomerase is associated with the generation of benign tumors as well as malignant tumors with characteristics of invasion and metastasis.
In this study, two tumor samples (cases 16 and 44) did not have any detectable telomerase activity. Moreover, telomerase activities were relatively low (less than 10 U/2 µg protein) in 6 samples of benign and malignant tumors; these included mammary gland adenomas (cases 12 and 13), mammary gland adenocarcinoma (case 20), perianal gland adenoma (case 22), basal cell tumor (case 34) and squamous cell carcinoma (case 36). These low levels of telomerase activity are conceivably suboptimal for maintenance of telomeric length. Although the telomerase activities were undetectable or low in these tumors, they might have telomerase-independent mechanisms for maintaining the length of telomeres as shown in some human tumors and cell lines [8] . As an example, recombination of telomeres is considered to be a mechanism for maintaining the length of telomeres in yeasts [16, 20] . Another possible explanation for the undetectable or low activity of telomerase in some tumor samples may be dilution of the tumor cells with nearby telomerase-negative normal somatic cells.
This identification in dogs of higher telomerase activity in tumors and undetectable or low activity in normal somatic tissues is significant because it points to using the dog as an animal model of telomerase activity that relates to the analogous system in humans. Although mice are often used as models for the study of human tumors, in terms of telomeres, they do not compare directly with human tumors. Most somatic tissues from mice possess distinct telomerase activities unlike those from humans [23, 28] , and telomeres in mice are >30 kb long as opposed to 10 to 20 kb long in humans [15] . When trying to assess the efficacy of telomerase inhibitors as new anti-tumor drugs in an animal model, a longer lived species may be preferable, because telomere shortening occurs slowly at a rate of about 50 to 100 bp per cell division [1, 4, 23] . For these reasons, the dog may be the animal of choice for investigations on telomeres and telomerase in humans although further studies are necessary to compare the length of telomeres and the system for maintenance of telomeres in various animal species.
